BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Crucell N.V. Doubles Production of Quinvaxem(R) in 2008 and Prepares Move to New Korean Production Site to Facilitate Growth

  October 21, 2008

   · 

  1 min read
• Business

  Raymond J. Ruddy Joins Psychemedics Corporation As Top Financial Officer

  October 21, 2008

   · 

  2 min read
• Drug Development

  Glycotex Inc. Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing

  October 21, 2008

   · 

  3 min read
• Business

  Schering-Plough Corporation (JOBS) Beats Forecast, as Vytorin Falls

  October 21, 2008

   · 

  16 min read
• Biotech Bay

  BiPar Sciences, Inc. to Present at the 7th Annual BIO Investor Forum in San Francisco

  October 21, 2008

   · 

  1 min read
• Drug Development

  Emisphere Technologies, Inc. Announces Initiation of Second Phase III Study for Oral Osteoarthritis Treatment

  October 21, 2008

   · 

  1 min read
• Pharm Country

  Ivivi Technologies, Inc. Comments On Nasdaq’s Temporary Suspension of Certain Marketplace Rules

  October 21, 2008

   · 

  1 min read
• Drug Development

  OXiGENE Announces Clinical Trials Interim Data Update to be Presented At the 12th Biennial Meeting of the International Gynecologic Cancer Society

  October 21, 2008

   · 

  1 min read
• Business

  Nanosphere, Inc. to Report 2008 3rd Quarter Earnings and Hold Investor Conference Call On Monday, November 10, 2008

  October 21, 2008

   · 

  1 min read
• BioCapital

  Insmed Incorporated Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule

  October 21, 2008

   · 

  2 min read